Baidu
map

2019 JSH指南:丙型肝炎病毒感染的管理

2020-04-28 日本肝脏学会 Hepatol Res. 2020 Apr 28.

日本肝脏学会(JSH)第一版丙型肝炎病毒感染管理指南于2012年发布。自此,随着丙型肝炎新药的上市和现有药物适应证的增加,该指南一直更新。随着索非布韦/维帕他韦的批准促使日本于2019年3月推出第7版

中文标题:

2019 JSH指南:丙型肝炎病毒感染的管理

英文标题:

JSH Guidelines for the Management of Hepatitis C Virus Infection: 2019 Update.

发布机构:

日本肝脏学会

发布日期:

2020-04-28

简要介绍:

日本肝脏学会(JSH)第一版丙型肝炎病毒感染管理指南于2012年发布。自此,随着丙型肝炎新药的上市和现有药物适应证的增加,该指南一直更新。随着索非布韦/维帕他韦的批准促使日本于2019年3月推出第7版丙型肝炎病毒感染管理指南。本文为该指南的英文版本,内容涵盖了丙肝治疗的一般信息,使用的药物、慢性肝炎和肝硬化的推荐治疗以及特殊人群丙肝的治疗。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=丙型肝炎病毒感染的管.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5b0f71c00190126e, title=2019 JSH指南:丙型肝炎病毒感染的管理, enTitle=JSH Guidelines for the Management of Hepatitis C Virus Infection: 2019 Update., guiderFrom=Hepatol Res. 2020 Apr 28., authorId=0, author=, summary=日本肝脏学会(JSH)第一版丙型肝炎病毒感染管理指南于2012年发布。自此,随着丙型肝炎新药的上市和现有药物适应证的增加,该指南一直更新。随着索非布韦/维帕他韦的批准促使日本于2019年3月推出第7版, cover=https://img.medsci.cn/202058/1588951944764_2020535.jpg, journalId=0, articlesId=null, associationId=813, associationName=日本肝脏学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Apr 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>日本肝脏学会(JSH)第一版丙型肝炎病毒感染管理指南于2012年发布。自此,随着丙型肝炎新药的上市和现有药物适应证的增加,该指南一直更新。随着索非布韦/维帕他韦的批准促使日本于2019年3月推出第7版丙型肝炎病毒感染管理指南。本文为该指南的英文版本,内容涵盖了丙肝治疗的一般信息,使用的药物、慢性肝炎和肝硬化的推荐治疗以及特殊人群丙肝的治疗。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=589, tagName=丙型肝炎)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=589, guiderKeyword=丙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2531, appHits=156, showAppHits=25, pcHits=727, showPcHits=2395, likes=1, shares=7, comments=3, approvalStatus=1, publishedTime=Fri May 08 23:57:40 CST 2020, publishedTimeString=2020-04-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri May 08 23:32:28 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:10:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=丙型肝炎病毒感染的管.pdf)])
丙型肝炎病毒感染的管.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1076537, encodeId=843510e653734, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:31:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076536, encodeId=d37e10e65366f, content=内容特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:30:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062757, encodeId=2af81062e5771, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:38:47 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-12-03 ms5000000508717642

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1076537, encodeId=843510e653734, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:31:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076536, encodeId=d37e10e65366f, content=内容特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:30:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062757, encodeId=2af81062e5771, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:38:47 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-12-03 ms5000000508717642

    内容特别好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1076537, encodeId=843510e653734, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:31:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076536, encodeId=d37e10e65366f, content=内容特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2955399522, createdName=ms5000000508717642, createdTime=Fri Dec 03 12:30:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062757, encodeId=2af81062e5771, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:38:47 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 谭永娇

    学习了

    0

拓展阅读

2014 EASL 丙型肝炎诊疗推荐建议

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2014-04-11

2014 英国指南共识:丙型肝炎的管理和直接抗病毒治疗

外国肝病科相关专家小组(统称) · 2014-04-22

2015 CASL共识指南:慢性丙型肝炎的管理(更新版)

加拿大肝病学会(CASL,Cannadian Association for the Study of the Liver) · 2015-01-13

丙型肝炎防治指南(2015更新版)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-04-20

2016年APASL共识建议:丙型肝炎的治疗

亚太肝脏研究学会(APASL,Asian-Pacific Association for the Study of the Liver) · 2016-06-08

丙型肝炎直接抗病毒药物临床试验评价专家建议

中国肝病科相关专家小组(统称) · 2016-06-08

Baidu
map
Baidu
map
Baidu
map